EHD1通过通过激活mTOR通路来向上调节HIF2a表达来促进乳腺癌转移
Xiaoqian Gao1,2, Juan Li1,2, Xuefei Feng1,3
1Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
概括
含有C端Eps15同源域的蛋白1 (EHD1) 通过激活AKT-mTOR通路和升调缺氧诱导因子2α (HIF2α) 来促进乳腺癌转移. 这项研究确定了EHD1作为抑制癌症传播的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 转移是乳腺癌死亡的主要原因.
- C端 Eps15 同源域含蛋白1 (EHD1) 参与瘤过程,但其在乳腺癌转移中的作用尚不清楚.
研究的目的:
- 阐明EHD1有助于乳腺癌转移的分子机制.
- 调查EHD1表达和患者转移之间的关联.
- 为了确定EHD1作为潜在的治疗点.
主要方法:
- 在体外二维和三维细胞培养模型.
- 在体内转移模型.
- 对EHD1表达和淋巴结转移的患者数据的分析.
- 西方涂抹测试用于评估蛋白质表达 (AKT-mTOR通路,HIF2α).
主要成果:
- 在乳腺癌患者中,EHD1上调与远程淋巴结转移相关.
- 在体外和体内,EHD1增强了表皮-介质细胞过渡 (EMT),侵袭和转移.
- EHD1激活AKT-mTOR通路,导致在正常条件下增加缺氧诱导因子2α (HIF2α).
- 这个EHD1-HIF2α轴促进乳腺癌的入侵和转移.
结论:
- EHD1是乳腺癌中HIF2α的新型调节者.
- EHD1通过AKT-mTOR/HIF2α通路促进乳腺癌转移.
- EHD1代表了克服乳腺癌转移的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


